Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
A personalized melanoma vaccine enters a Phase III study, while a pancreatic cancer vaccine moves on to Phase II.
Thermo Fisher Scientific was sued for knowingly profiting from Henrietta Lacks’s extraordinary tissue sample and cell line.
Researchers are working on vaccines that will target multiple flu or coronavirus strains.
Moderna and Merck’s customized neoantigen vaccine plus Keytruda lowered the risk for metastasis or death by 65%.
Experimental flu vaccine, designed to elicit immunity against a broad range of influenza viruses, performed well in a small trial.
Moderna and Merck’s personalized neoantigen vaccine plus checkpoint inhibitor lowered the risk of disease progression after surgery by 44%.
Unlike custom-made vaccines, those that target common cancer antigens could be available off the shelf.
The experimental vaccine trains the immune system to recognize HER2 proteins on breast tumors.
Vaccines are tested for safety, but like all medical products, they can sometimes cause side effects.
NIAID-supported research sheds light on why healthy people of the same age respond differently to vaccines.
A personalized cancer vaccine plus Keytuda lowered the risk of melanoma coming back after surgery.
A single vaccine dose delivered to nose aims to protect children and adults against COVID.
NIH study finds therapeutic vaccine administered via IV infusion improves tumor-fighting T-cell action in mice.
EBV causes mononucleosis and certain cancers, and it may play a role in multiple sclerosis and long COVID.
Nearly all HIV-positive study participants achieved protective antibody levels after two doses of Heplisav-B.
A mathematical technique called matrix completion could speed up the development of vaccines for flu and COVID-19 variants.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.